Post-COVID-19 hematologic complications: a systematic review

References

• Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017–1032.
   PubMed Web of Science ®Google Scholar
• Alahyari S, Rajaeinejad M, Jalaeikhoo H, et al. Immunological evaluation of patients with 2019 novel coronavirus pneumonia: CD4+ and CD16+ cells may predict severity and prognosis. PLoS One. 2022;17(8):e0268712. DOI: 10.1371/journal.pone.
   PubMedGoogle Scholar
• Alahyari S, Rajaeinejad M, Jalaeikhoo H, et al. Regulatory t cells in immunopathogenesis and severity of COVID-19: a systematic review. Arch Iran Med. 2022;25(2):127–132.
   PubMedGoogle Scholar
• Ahmed H, Patel K, Greenwood DC, et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta-analysis. J Rehabil Med. 2020;52(5):jrm00063.
   Google Scholar
• Hui D, Joynt G, Wong K, et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax. 2005;60:401.
   PubMed Web of Science ®Google Scholar
• Lee SH, Shin HS, Park HY, et al. Depression as a mediator of chronic fatigue and post-traumatic stress symptoms in middle east respiratory syndrome survivors. Psychiatry Investig. 2019;16:59–64.
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513.
   PubMed Web of Science ®Google Scholar
• Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease. The New England Journal of Medicine. 2020 2019 in China;382:1708–1720.
   PubMed Web of Science ®Google Scholar
• Chammard TB, Schepers K, Breurec S, et al. Severe thrombocytopenia after zika virus infection, Guadeloupe, 2016. Emerg Infect Dis. 2017;23:696.
   PubMed Web of Science ®Google Scholar
• Bhattacharjee S, Banerjee M. Immune thrombocytopenia secondary to COVID-19: a systematic review. Sn Compr Clin Med. 2020;2:1.
   Google Scholar
• Sumbly V, Siddiqui R, Alshamam M, et al. New onset aplastic anemia after a COVID-19 infection: a case report. Am J Med Case Reports, Vol 9, 2021, 451–455. 2021 9:451–5
   Google Scholar
• Jawed M, Hart E, Saeed M. Haemolytic anaemia: a consequence of COVID-19. BMJ Case Rep. 2020;13(12):e238118.
   Google Scholar
• Klok FA, Kruip MJHA, NJM VDM, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res. 2020;191:148–150.
   PubMed Web of Science ®Google Scholar
• Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46:1089–1098.
   PubMed Web of Science ®Google Scholar
• Thomas W, Varley J, Johnston A, et al. Thrombotic complications of patients admitted to intensive care with COVID-19 at a teaching hospital in the United Kingdom. Thromb Res. 2020;191:76–77.
   PubMedGoogle Scholar
• Poissy J, Goutay J, Caplan M, et al. Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence. Circulation. 2020;142:184–186.
   PubMed Web of Science ®Google Scholar
• Llitjos JF, Leclerc M, Chochois C, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020;18:1743–1746.
   PubMed Web of Science ®Google Scholar
• Middeldorp S, Coppens M, van Haaps TF, et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18:1995–2002.
   PubMed Web of Science ®Google Scholar
• Al-Samkari H, Karp Leaf RS, Dzik WH, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020;136:489–500.
   PubMed Web of Science ®Google Scholar
• Lodigiani C, Iapichino G, Carenzo L, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020;191:9–14.
   PubMed Web of Science ®Google Scholar
• Levi M, Thachil J. Coronavirus Disease 2019 Coagulopathy: disseminated Intravascular Coagulation and Thrombotic Microangiopathy-Either, Neither, or Both. Semin Thromb Hemost. 2020;46:781–784.
   Google Scholar
• Levi M, Hunt BJ. Thrombosis and coagulopathy in COVID‐19: an illustrated review. Res Pract Thromb Haemost. 2020;4:744.
   PubMedGoogle Scholar
• Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC State-of-the-art review. J Am Coll Cardiol. 2020;75:2950–2973.
   PubMed Web of Science ®Google Scholar
• Aktaa S, Wu J, Nadarajah R, et al. Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: multi-sourced population-based health records cohort study. Thromb Res. 2021;202:17–23.
   PubMedGoogle Scholar
• Artifoni M, Danic G, Gautier G, et al. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors. J Thromb Thrombolysis. 2020;50:211–216.
   PubMed Web of Science ®Google Scholar
• Bellmunt-Montoya S, Riera C, Gil D, et al. COVID-19 infection in critically Ill patients carries a high risk of venous thrombo-embolism. Eur J Vasc Endovasc Surg. 2021;61:628–634.
   PubMedGoogle Scholar
• Betoule A, Martinet C, Gasperini G, et al. Diagnosis of venous and arterial thromboembolic events in COVID-19 virus-infected patients. J Thromb Thrombolysis. 2020;50:302–304.
   PubMedGoogle Scholar
• Beun R, Kusadasi N, Sikma M, et al. Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2. Int J Lab Hematol. 2020;42:19–20.
   PubMed Web of Science ®Google Scholar
• Beyls C, Huette P, Abou-Arab O, et al. Extracorporeal membrane oxygenation for COVID-19-associated severe acute respiratory distress syndrome and risk of thrombosis. Br J Anaesth. 2020;125:e260–2.
   PubMedGoogle Scholar
• Bilaloglu S, Aphinyanaphongs Y, Jones S, et al. Thrombosis in hospitalized patients with COVID-19 in a New York city health system. J Am Med Assoc. 2020;324:799–801.
   PubMed Web of Science ®Google Scholar
• Bompard F, Monnier H, Saab I, et al. Pulmonary embolism in patients with COVID-19 pneumonia. Eur Respir J. 2020;56(1):2001365.
   Google Scholar
• Cantador E, Núñez A, Sobrino P, et al. Incidence and consequences of systemic arterial thrombotic events in COVID-19 patients. J Thromb Thrombolysis. 2020;50:543–547.
   PubMed Web of Science ®Google Scholar
• Cattaneo M, Bertinato EM, Birocchi S, et al. Pulmonary embolism or pulmonary thrombosis in COVID-19? Is the recommendation to use high-dose heparin for thromboprophylaxis justified? Thromb Haemost. 2020; 120: 1230–1232.
   Google Scholar
• Chen S, Zhang D, Zheng T, et al. DVT incidence and risk factors in critically ill patients with COVID-19. J Thromb Thrombolysis. 2021;51:33–39.
   PubMedGoogle Scholar
• Criel M, Falter M, Jaeken J, et al. Venous thromboembolism in SARS-CoV-2 patients: only a problem in ventilated ICU patients, or is there more to it? Eur Respir J. 2020;56:8–11.
   Google Scholar
• Cui S, Chen S, Li X, et al. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18:1421–1424.
   PubMed Web of Science ®Google Scholar
• Demelo-Rodríguez P, Cervilla-Muñoz E, Ordieres-Ortega L, et al. Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels. Thromb Res. 2020;192:23–26.
   PubMed Web of Science ®Google Scholar
• Desborough MJR, Doyle AJ, Griffiths A, et al. Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom. Thromb Res. 2020;193:1–4.
   PubMedGoogle Scholar
• Elbadawi A, Elgendy IY, Sahai A, et al. Incidence and outcomes of thrombotic events in symptomatic patients with COVID-19. Arterioscler Thromb Vasc Biol. 2021;41:545–547.
   PubMedGoogle Scholar
• Engelen MM, Vandenbriele C, Balthazar T, et al. Venous thromboembolism in patients discharged after COVID-19 hospitalization. Semin Thromb Hemost. 2021;47:362–671.
   PubMedGoogle Scholar
• Fraissé M, Logre E, Pajot O, et al. Thrombotic and hemorrhagic events in critically ill COVID-19 patients: a French monocenter retrospective study. Crit Care. 2020;24:1–4.
   PubMedGoogle Scholar
• García-Ortega A, Oscullo G, Calvillo P, et al. Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection: pulmonary embolism in COVID-19 infection. J Infect. 2021;82:489–500.
   Google Scholar
• Grandmaison G, Andrey A, Périard D, et al. Systematic screening for venous thromboembolic events in COVID-19 Pneumonia. TH Open. 2020;04:e113–5.
   Google Scholar
• Grein J, Ohmagari N, Shin D, et al. Compassionate use of remdesivir for patients with severe COVID-19. N Engl J Med. 2020;382:2327–2336.
   PubMed Web of Science ®Google Scholar
• Grillet F, Behr J, Calame P, et al. Acute pulmonary embolism associated with COVID-19 pneumonia detected with pulmonary CT angiography. Radiology. 2020;296:E186–8.
   PubMed Web of Science ®Google Scholar
• Helms J, Severac F, Merdji H, et al. Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients: bi-center cohort study. Ann Intensive Care . 2021;11(1):14.
   PubMedGoogle Scholar
• Inciardi RM, Adamo M, Lupi L, et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J. 2020;41:1821–1829.
   PubMed Web of Science ®Google Scholar
• Li JY, Wang HF, Yin P, et al. Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: a multicenter retrospective study. J Thromb Haemost. 2021;19:1038–1048.
   PubMedGoogle Scholar
• Kaptein FHJ, Stals MAM, Grootenboers M; Covid D, Coalition T, Kaptein FHJ, et al. Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave. Thromb Res. 2021;199:143–148.
   PubMedGoogle Scholar
• Klok FA, Kruip MJHA, van der Meer NJM, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res. 2020;191:148–150.
   PubMed Web of Science ®Google Scholar
• Klok FA, Kruip MJHA, NJM VDM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–147.
   PubMed Web of Science ®Google Scholar
• Léonard-Lorant I, Delabranche X, Séverac F, et al. Acute pulmonary embolism in patients with COVID-19 at CT angiography and relationship to d-dimer levels. Radiology. 2020;296:E189–91.
   PubMed Web of Science ®Google Scholar
• Longchamp A, Longchamp J, Manzocchi-Besson S, et al. Venous thromboembolism in critically Ill patients with COVID-19: results of a screening study for deep vein thrombosis. Res Pract Thromb Haemost. 2020;4:842–847.
   PubMed Web of Science ®Google Scholar
• Maatman TK, Jalali F, Feizpour C, et al. Routine venous thromboembolism prophylaxis may be inadequate in the hypercoagulable state of severe coronavirus disease 2019. Crit Care Med. 2020;31:E783–90.
   Google Scholar
• Nahum J, Morichau-Beauchant T, Daviaud F, et al. Venous thrombosis among critically ill patients with coronavirus disease 2019 (COVID-19). JAMA Netw Open. 2020;3:3–6.
   Google Scholar
• Patell R, Bogue T, Koshy A, et al. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood. 2020;136:1342–1346.
   PubMed Web of Science ®Google Scholar
• Poyiadji N, Cormier P, Patel PY, et al. Acute pulmonary embolism and COVID-19. Radiology. 2020;297:E335–8.
   PubMedGoogle Scholar
• Ren B, Yan F, Deng Z, et al. Extremely high incidence of lower extremity deep venous thrombosis in 48 Patients with Severe COVID-19 in Wuhan. Circulation. 2020;142:181–183.
   PubMed Web of Science ®Google Scholar
• Rey JR, Caro-Codón J, Pineda DP, et al. Complicaciones arteriales trombóticas en pacientes hospitalizados con COVID-19. Rev Esp Cardiol. 2020;73:769.
   Google Scholar
• Roberts LN, Whyte MB, Georgiou L, et al. Postdischarge venous thromboembolism following hospital admission with COVID-19. Blood. 2020;136:1347–1350.
   PubMed Web of Science ®Google Scholar
• Salisbury R, Iotchkova V, Jaafar S, et al. Incidence of symptomatic, image-confirmed venous thromboembolism following hospitalization for COVID-19 with 90-day follow-up. Blood Adv. 2020;4:6230–6239.
   PubMedGoogle Scholar
• Siguret V, Voicu S, Neuwirth M, et al. Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients? Thromb Res. 2020;195:74–76.
   PubMed Web of Science ®Google Scholar
• Spiezia L, Boscolo A, Poletto F, et al. COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb Haemost. 2020;120:998–1000.
   PubMed Web of Science ®Google Scholar
• Stoneham SM, Milne KM, Nuttall E, et al. Thrombotic risk in COVID-19: a case series and case-control study. Clin Med (Lond). 2020;20. E76–E81.
   PubMed Web of Science ®Google Scholar
• Tavazzi G, Civardi L, Caneva L, et al. Thrombotic events in SARS-CoV-2 patients: an urgent call for ultrasound screening. Intensive Care Med. 2020;46:1121–1123.
   PubMed Web of Science ®Google Scholar
• Tholin B, Ghanima W, Einvik G, et al. Incidence of thrombotic complications in hospitalised and non-hospitalised patients after COVID-19 diagnosis. Br J Haematol. 2021;194:542–546.
   PubMedGoogle Scholar
• Voicu S, Bonnin P, Stépanian A, et al. High prevalence of deep vein thrombosis in mechanically ventilated COVID-19 patients. J Am Coll Cardiol . 2020;76:480–482.
   PubMed Web of Science ®Google Scholar
• Zerwes S, Hernandez Cancino F, Liebetrau D, et al. Erhöhtes Risiko für tiefe Beinvenenthrombosen bei Intensivpatienten mit CoViD-19-Infektion? – Erste Daten [Increased risk of deep vein thrombosis in intensive care unit patients with CoViD-19 infections?-Preliminary data]. Chirurg. 2020;91(7):588-594.
   Google Scholar
• Zhang L, Feng X, Zhang D, et al. Deep vein thrombosis in hospitalized patients with COVID-19 in Wuhan, China: prevalence, risk factors, and outcome. Circulation. 2020;142:114–128.
   PubMed Web of Science ®Google Scholar
• Chen W, Yang B, Li Z, et al. Sudden severe thrombocytopenia in a patient in the recovery stage of COVID-19. Lancet Haematol. 2020;7:e624.
   PubMed Web of Science ®Google Scholar
• Bomhof G, Mutsaers PGNJ, Leebeek FWG, et al. COVID-19-associated immune thrombocytopenia. Br J Haematol. 2020;190:e61–4.
   PubMedGoogle Scholar
• Murt A, Eskazan AE, Yılmaz U, et al. COVID-19 presenting with immune thrombocytopenia: a case report and review of the literature. J Med Virol. 2021; 93:43–45.
   Google Scholar
• Rosenzweig JD, McThenia SS, Kaicker S. SARS-CoV-2 infection in two pediatric patients with immune cytopenias: a single institution experience during the pandemic. Pediatr Blood Cancer. 2020;67:e28503.
   Google Scholar
• Pascolini S, Granito A, Muratori L, et al. Coronavirus disease associated immune thrombocytopenia: causation or correlation? J Microbiol Immunol Infect. 2021;54:531–533.
   PubMedGoogle Scholar
• Tsao HS, Chason HM, Fearon DM. Immune thrombocytopenia (ITP) in a pediatric patient positive for SARS-CoV-2. Pediatrics. 2020;146. 10.1542/peds.2020-1419
   Web of Science ®Google Scholar
• Zulfiqar AA, Lorenzo-Villalba N, Hassler P, et al. Immune thrombocytopenic purpura in a patient with COVID-19. N Engl J Med. 2020;382:e43.
   PubMed Web of Science ®Google Scholar
• Humbert S, Razanamahery J, Payet-Revest C, et al. COVID-19 as a cause of immune thrombocytopenia. Med Mal Infect. 2020;50:459.
   PubMed Web of Science ®Google Scholar
• Guirguis N, Rehman T, Shams Y, et al. Sars-cov-2 infection inducing immune thrombocytopenic purpura: case series. Ochsner J. 2021;21:187–189.
   PubMedGoogle Scholar
• Wu X, Luo D, Liu Y, et al. Continuous thrombocytopenia after SARS-CoV-2 nucleic acid negative in a non-severe COVID-19 patient for several months. BMC Infect Dis. 2020;20(1):774.
   PubMedGoogle Scholar
• Stepman G, Daley I, Bralts D, et al. A Case of Immune Thrombocytopenia After COVID-19 Infection. Cureus. 2021;13(6):e15843.
   PubMedGoogle Scholar
• Pedroso A, Frade L, Trevas S, et al. Immune thrombocytopenic purpura – different presentations in two COVID-19 patients. Cureus. 2020;12(10):e11202.
   PubMedGoogle Scholar
• Mariani R, Liu H. Severe transient pancytopenia with dyserythropoiesis and dysmegakaryopoiesis in COVID-19-associated MIS-C. Blood. 2020;136:2964.
   PubMedGoogle Scholar
• Deng Y, Liu W, Liu K, et al. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study. Chin Med J (Engl). 2020;133:1261–1267.
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062.
   PubMed Web of Science ®Google Scholar
• Pavoni V, Gianesello L, Pazzi M, et al. Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia. J Thromb Thrombolysis. 2020;50:281–286.
   PubMed Web of Science ®Google Scholar
• Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135:2033–2040.
   PubMed Web of Science ®Google Scholar
• Goshua G, Pine AB, Meizlish ML, et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7:e575–82.
   PubMed Web of Science ®Google Scholar
• Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417.
   PubMed Web of Science ®Google Scholar
• Ramlall V, Thangaraj PM, Meydan C, et al. Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection. Nat Med. 2020;26:1609–1615.
   PubMedGoogle Scholar
• Skendros P, Mitsios A, Chrysanthopoulou A, et al. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J Clin Invest. 2020;130:6151–6157.
   PubMed Web of Science ®Google Scholar
• Hottz ED, Azevedo-Quintanilha IG, Palhinha L, et al. Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19. Blood. 2020;136:1330–1341.
   PubMed Web of Science ®Google Scholar
• Barrett TJ, Lee AH, Xia Y, et al. Platelet and vascular biomarkers associate with thrombosis and death in coronavirus disease. Circ Res. 2020;127:945.
   PubMed Web of Science ®Google Scholar
• Middleton EA, He XY, Denorme F, et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020;136:1169–1179.
   PubMed Web of Science ®Google Scholar
• Zuo Y, Yalavarthi S, Shi H, et al. Neutrophil extracellular traps in COVID-19. JCI Insight. 2020;5(11):e138999.
   Web of Science ®Google Scholar
• Bikdeli B, Madhavan MV, Gupta A, et al. Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research. Thromb Haemost. 2020;120:1004–1024.
   PubMed Web of Science ®Google Scholar
• Nougier C, Benoit R, Simon M, et al. Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis. J Thromb Haemost. 2020;18:2215–2219.
   PubMed Web of Science ®Google Scholar
• Thachil J. Hypoxia-An overlooked trigger for thrombosis in COVID-19 and other critically ill patients. J Thromb Haemost. 2020;18:3109–3110.
   PubMed Web of Science ®Google Scholar
• Abou-Ismail MY, Diamond A, Kapoor S, et al. The hypercoagulable state in COVID-19: incidence, pathophysiology, and management. Thromb Res. 2020;194:101.
   PubMed Web of Science ®Google Scholar
• Boulware R, Refaai MA. Why do patients with immune thrombocytopenia (ITP) experience lower bleeding events despite thrombocytopenia? Thromb Res. 2020;187:154–158.
   PubMed Web of Science ®Google Scholar
• Li X, Jeffers LJ, Garon C, et al. Persistence of hepatitis C virus in a human megakaryoblastic leukaemia cell line. J Viral Hepat. 1999;6:107–114.
   PubMed Web of Science ®Google Scholar
• Afdhal N, McHutchison J, Brown R, et al. Thrombocytopenia associated with chronic liver disease. J Hepatol. 2008;48:1000–1007.
   PubMed Web of Science ®Google Scholar
• Chelucci C, Federico M, Guerriero R, et al. Productive Human immunodeficiency virus-1 infection of purified megakaryocytic progenitors/precursors and maturing megakaryocytes. Blood. 1998;91:1225–1234.
   PubMed Web of Science ®Google Scholar
• Yeaman MR. Platelets in defense against bacterial pathogens. Cell Mol Life Sci. 2010;67:525–544.
   PubMed Web of Science ®Google Scholar
• Goeijenbier M, van Wissen M, van de Weg C, et al. Review: viral infections and mechanisms of thrombosis and bleeding. J Med Virol. 2012;84:1680–1696.
   PubMed Web of Science ®Google Scholar
• Cines DB, Liebman H, Stasi R. Pathobiology of secondary immune thrombocytopenia. Semin Hematol. 2009;46(1 Suppl 2):S2–14.
   Web of Science ®Google Scholar
• Ulrich H, Pillat MM. CD147 as a target for COVID-19 treatment: suggested effects of azithromycin and stem cell engagement. Stem Cell Rev Rep. 2020;16:434–440.
   PubMed Web of Science ®Google Scholar
• Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol . 2020;99:1205.
   PubMed Web of Science ®Google Scholar
• Young NS; Young NS. Aplastic Anemia. Longo DL, editor. N Engl J Med. 2018;379:1643–1656.
   PubMed Web of Science ®Google Scholar
• King KY, Goodell MA; King KY, Goodell MA. Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat Rev Immunol. 2011;11:685–692.
   PubMed Web of Science ®Google Scholar
• Fara A, Mitrev Z, Rosalia RA, et al. Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines. Open Biol. 2020;10(9):200160.
   Web of Science ®Google Scholar
• Huerga Encabo H, Grey W, Garcia-Albornoz M, et al. Human erythroid progenitors are directly infected by SARS-CoV-2: implications for emerging erythropoiesis in Severe COVID-19 Patients. Stem Cell Reports. 2021;16:428–436.
   PubMed Web of Science ®Google Scholar
• Gillespie MA, Palii CG, Sanchez-Taltavull D, et al. Absolute quantification of transcription factors reveals principles of gene regulation in erythropoiesis. Mol Cell. 2020;78:960–74.e11.
   PubMed Web of Science ®Google Scholar
• Issa N, Lacassin F, Camou F. First case of persistent pancytopenia associated with SARS-CoV-2 bone marrow infiltration in an immunocompromised patient. Ann Oncol Off J Eur Soc Med Oncol. 2020;31:1418–1419.
   PubMed Web of Science ®Google Scholar